Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
‘Novel approach’ to treating Alzheimer’s disease discovered — it’s a gas
Breathe easy — researchers say they may have found an innovative approach to treating Alzheimer’s disease. There is no cure for the brain disorder, which affects more than 6 million Americans. Treatment progress has been slow because scientists don’t fully understand what causes the complex disease.
New study suggests ultrasound might be a promising treatment for Alzheimer’s disease
Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical trial has demonstrated the potenti
A Breath Away From a Cure: How Xenon Gas Could Transform Alzheimer’s Treatment
A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ability to mitigate brain damage and improve cognitive functions in mouse models.
Mountain climbing and treating Alzheimer's: Could xenon gas have potential?
In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped reduce levels of brain atrophy and neuroinflammation.
Xenon gas could protect against Alzheimer's disease: Mouse study
Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble -- approach: using Xenon gas.
Could inhaling xenon gas help treat Alzheimer’s? A new mouse study suggests it might
But a new mouse study shows one possible use case for xenon — as a treatment for Alzheimer’s disease. The paper, published Wednesday in Science Translational Medicine, shows the potential of inhaled xenon to activate the brain’s immune cells,
3d
on MSN
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...
FIU News
1d
Promising new drug candidate for Alzheimer’s
Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...
verywellhealth
4d
Zunveyl: An Improved Alzheimer's Drug With Fewer Side Effects Will Be Available Soon
Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.
Rolling Out
13d
Dopamine’s surprising breakthrough in Alzheimer’s treatment
Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...
Benzinga.com
4d
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
FDA sets August 31, 2025, as the action date for Eisai and Biogen'
s
Leqembi subcutaneous autoinjector application.
Monthly Prescribing Reference
1d
Lecanemab SC Formulation Under Review for Early Alzheimer Disease
The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...
Rolling Out
7d
Herpes virus may play a key role in Alzheimer’s disease
Research reveals how herpes simplex virus-1 may contribute to Alzheimer’s disease, offering new insights into the disease’s ...
2d
on MSN
National Alzheimer’s Association’s 10-year vision includes big changes in treatment and detection
Quality time takes on a whole new meaning after an Alzheimer’s diagnosis. “We just finished a two-week European River cruise, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback